The effect of dexamethasone on the peripheral plasma levels of progesterone was investgated in pregnant women during the first trimester. Neither oral treatment (2.5 mg \m=x\4 for two days) nor intramuscular injection (24\p=n-\64 mg) had any depressant effect in otherwise untreated women.
The incremental response in the plasma progesterone levels consistently seen in women subjected to continuous dilation of the uterine cervix or vasopressin infusions, was markedly reduced by dexamethasone treatment.
Continuous cervical dilation has previously been shown to cause a marked increase in the plasma progesterone and gonadotrophin levels during early human pregnancy (Fylling 8c Norman 1970) . The increase in the progesterone level can be blocked by the /3-receptor blocking agent, propranolol (Fylling 1971¿) . In sheep, premature parturition can be induced by dexamethasone which causes a fall in the peripheral plasma progesterone level (Fylling 1971c) similar to that observed before normal parturition in this species (Fylling 1970 ).
The present investigation deals with the effect of dexamethasone on the plasma progesterone levels in otherwise untreated women and in women sub¬ jected to cervical dilation or vasopressin infusion in the first trimester of pregnancy.
MATERIAL AND METHODS

Subjects
Seventy seven pregnant women, 19-31 years old, were included in the investigation. Thirty women were randomly selected in order to study the influence of dexa¬ methasone on the effect of cervical dilation on the peripheral plasma progesterone values (Fig. 1) . Ten of the women received 32 mg of dexamethasone as a single intra¬ muscular injection simultaneously with the insertion of the dilating instrument which has been described in a previous paper (Fylling Sc Norman 1970 Progesterone assay procedure Duplicate measurements of progesterone in 0.25 ml plasma samples were performed by the rapid protein binding technique described by Johansson (1969) with minor modifications (Fylling 1970 In the previous reports (Fylling & Norman 1970; Fylling 1971a,b) it was sug¬ gested that cervical dilation or vasopressin infusion might exert its stimulating effect via 3',5'-adenosine monophosphate (cyclic AMP). It was also demon-1 strated that the effect could be blocked by a /î-receptor blocking agent, in¬ dicating that the adenyl cyclase system might be closely related to the ß-receptors (Robinson et al. 1967; Fylling 1971 ) . As shown in Tables 1 and 2 neither a single intramuscular injection nor daily administration of dexamethasone was able to decrease the plasma pro¬ gesterone levels during the observation periods in otherwise untreated women. In view of the observations on premature parturition in sheep during dexa¬ methasone administration (Fylling 1971c ), the present results might indicate a more marked autonomy of the human foeto-placental unit than that of the sheep. The results presented in Fig. 1 , however, are not directly comparable since the investigations were performed at different gestational ages. Never¬ theless, the results presented in Fig. 1 indicate that dexamethasone is able to block or reduce the incremental response both to cervical dilation and to vaso¬ pressin infusion.
There are several possible explanations for the blocking effect of dexa¬ methasone described in this paper. 1) The drug might exert its blocking effect via the adenyl cyclase or /¡-receptor system as discussed for propranolol in a previous paper (Fylling 1971¿ (Feder et al. 1971 ). Hence, it is possible that the drug exerts its blocking effect via neurohormonal control systems. This would, however, imply the involve¬ ment of such systems during normal pregnancy, which seems unlikely, since it is known that pregnancy in the human subject can proceed in the absence of a functioning pituitary gland (reviewed by Vorherr 1968 ).
At present, no final conclusion seems warranted regarding the mechanism by which dexamethasone influences the function of the foeto-placental unit.
